Hirofumi Michimae (Hiroshi Michimae)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Top Venues

Journal of gynecologic oncology

Entropy (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hiromi Komazaki, Kazuaki Takahashi, Hiroshi Tanabe, Yuichi Shoburu, Misato Kamii, Akina Tsuda, Motoaki Saito, Kyosuke Yamada, Hirokuni Takano, Hirofumi Michimae, Aikou Okamoto
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer. Journal of gynecologic oncology (2024)
Takeshi Emura, Hirofumi Michimae, Shigeyuki Matsui
Dynamic Risk Prediction via a Joint Frailty-Copula Model and IPD Meta-Analysis: Building Web Applications. Entropy (Basel, Switzerland) 24 (5) (2022)
Takashi Motohashi, Akira Yabuno, Hirofumi Michimae, Tetsuro Ohishi, Miwa Nonaka, Masashi Takano, Shin Nishio, Hiroyuki Fujiwara, Keiichi Fujiwara, Asumi Okumura, Toru Sugiyama, Tsutomu Tabata
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial. Journal of gynecologic oncology 32 (1) (2020)